| Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study J Geisler, B Haynes, G Anker, M Dowsett, PE Lønning Journal of Clinical Oncology 20 (3), 751-757, 2002 | 715 | 2002 |
| Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2× 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan … G Gulati, SL Heck, AH Ree, P Hoffmann, J Schulz-Menger, MW Fagerland, ... European heart journal 37 (21), 1671-1680, 2016 | 700 | 2016 |
| In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients. J Geisler, N King, G Anker, G Ornati, E Di Salle, PE Lønning, M Dowsett Clinical cancer research: an official journal of the American Association …, 1998 | 408 | 1998 |
| Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer J Geisler, N King, M Dowsett, L Ottestad, S Lundgren, P Walton, ... British journal of cancer 74 (8), 1286-1291, 1996 | 408 | 1996 |
| Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer PE Lønning, J Geisler, LE Krag, B Erikstein, Y Bremnes, AI Hagen, ... Journal of Clinical Oncology 23 (22), 5126-5137, 2005 | 344 | 2005 |
| Gene expression profiling–based identification of molecular subtypes in stage IV melanomas with different clinical outcome G Jönsson, C Busch, S Knappskog, J Geisler, H Miletic, M Ringnér, ... Clinical cancer research 16 (13), 3356-3367, 2010 | 296 | 2010 |
| TP53 Gene Mutations Predict the Response to Neoadjuvant Treatment with 5-Fluorouracil and Mitomycin in Locally Advanced Breast Cancer S Geisler, AL Børresen-Dale, H Johnsen, T Aas, J Geisler, LA Akslen, ... Clinical Cancer Research 9 (15), 5582-5588, 2003 | 189 | 2003 |
| Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators J Geisler The Journal of steroid biochemistry and molecular biology 86 (3-5), 245-253, 2003 | 177 | 2003 |
| Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels J Geisler, H Helle, D Ekse, NK Duong, DB Evans, Y Nordbø, T Aas, ... Clinical cancer research 14 (19), 6330-6335, 2008 | 163 | 2008 |
| Olaparib monotherapy as primary treatment in unselected triple negative breast cancer HP Eikesdal, S Yndestad, A Elzawahry, A Llop-Guevara, B Gilje, ES Blix, ... Annals of oncology 32 (2), 240-249, 2021 | 142 | 2021 |
| Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer J Geisler, S Detre, H Berntsen, L Ottestad, B Lindtjørn, M Dowsett, ... Clinical Cancer Research 7 (5), 1230-1236, 2001 | 142 | 2001 |
| Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors A Tahiri, SK Leivonen, T Lüders, I Steinfeld, M Ragle Aure, J Geisler, ... Carcinogenesis 35 (1), 76-85, 2014 | 141 | 2014 |
| Aromatase inhibition: translation into a successful therapeutic approach J Geisler, PE Lønning Clinical Cancer Research 11 (8), 2809-2821, 2005 | 132 | 2005 |
| Molecular profiling reveals low-and high-grade forms of primary melanoma K Harbst, J Staaf, M Lauss, A Karlsson, A Måsbäck, I Johansson, ... Clinical cancer research 18 (15), 4026-4036, 2012 | 120 | 2012 |
| Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole–of clinical importance? J Geisler British journal of cancer 104 (7), 1059-1066, 2011 | 118 | 2011 |
| A novel HPLC-RIA method for the simultaneous detection of estrone, estradiol and estrone sulphate levels in breast cancer tissue J Geisler, H Berntsen, PE Lønning The Journal of steroid biochemistry and molecular biology 72 (5), 259-264, 2000 | 118 | 2000 |
| Intratumoral estrogen disposition in breast cancer BP Haynes, AH Straume, J Geisler, R A'Hern, H Helle, IE Smith, ... Clinical Cancer Research 16 (6), 1790-1801, 2010 | 115 | 2010 |
| Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomised, placebo-controlled study J Geisler, PE Lønning, LE Krag, E Løkkevik, T Risberg, AI Hagen, ... European Journal of Cancer 42 (17), 2968-2975, 2006 | 113 | 2006 |
| Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status PE Lønning, H Helle, NK Duong, D Ekse, T Aas, J Geisler The Journal of steroid biochemistry and molecular biology 117 (1-3), 31-41, 2009 | 111 | 2009 |
| Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome MR Aure, V Vitelli, S Jernström, S Kumar, M Krohn, EU Due, TH Haukaas, ... Breast Cancer Research 19, 1-18, 2017 | 103 | 2017 |
